Clinical Trials in Atlanta

Showing 6641-6660 of 19,805 trials

Phase I/II Eval Safety & Prelim Activity Nivolumab Comb W/Vorolanib Pts W/Refractory Thoracic Tumors

NCT03583086

This is a two-agent, open-label, non-randomized, Phase 1/2 dose escalation and dose expansion study of combinatorial oral vorolanib plus infusional nivolumab in patients with Non-Small Cell Lung Cancer naïve to checkpoint inhibitor therapy, Non-Small Cell Lung Cancer who have progressed on checkpoint inhibitor therapy, Small Cell Lung Cancer ( who have progressed on platinum-based chemotherapy, and thymic carcinoma.

Thymic CarcinomaNon-small Cell Lung CancerRefractory Thoracic Tumors+1 more

Vanderbilt-Ingram Cancer Center88 participantsStarted Jul 2018

Palo Alto, California, United States • Atlanta, Georgia, United States • Chicago, Illinois, United States +4 more locations

COMPLETEDNA< 1 mile

Noninvasive Peripheral Nerve Stimulation for Medication-Refractory Primary RLS (The RESTFUL Study)

NCT04874155

Multi-center, prospective double-blind randomized controlled pivotal study of noninvasive peripheral nerve stimulation (NPNS) with the NTX100 Neuromodulation System for patients with medication-refractory moderate-severe primary RLS

Restless Legs Syndrome

Noctrix Health, Inc.133 participantsStarted May 2021

San Leandro, California, United States • Colorado Springs, Colorado, United States • Atlanta, Georgia, United States +4 more locations

Phase I/II Eval Safety & Prelim Activity Nivolumab Comb W/Vorolanib Pts W/Refractory Thoracic Tumors

Noninvasive Peripheral Nerve Stimulation for Medication-Refractory Primary RLS (The RESTFUL Study)

Find Trials by Condition in Atlanta

BEFAST (Bubble-Enhanced FAST) for the Evaluation of Solid Organ Injury

Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis

Open- Label Trial of Sipuleucel-T Administered to Active Surveillance Patients for Newly Diagnosed Prostate Cancer

Influence of Fast and Slow Imagined Muscle Contractions on Muscle Function or Central Nervous System Properties

Brief Title: Study of Efficacy and Safety of Canakinumab as Adjuvant Therapy in Adult Subjects With Stages AJCC/UICC v. 8 II-IIIA and IIIB (T>5cm N2) Completely Resected Non-small Cell Lung Cancer Acronym: CANOPY-A

This Was a Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS).

Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (INTEGUMENT-II)

Study to Assess Safety, Tolerability and Efficacy of SC Administered MBL949 in Obese Participants With or Without T2DM

Investigating Social Competence in Youth With Autism

A Comparison of Ureteroscopic Treatment of Nephrolithiasis With and Without Moses Technology

REmodeling the Left Ventricle With Atrial Modulated Pacing

Study of LAU-7b in the Treatment of Cystic Fibrosis in Adults

A Study of LY3002813 in Participants With Memory Damage Due to Alzheimer's Disease (AD) or AD

Extension Treatment Using EryDex System in Patients With AT Who Participated in the ATTeST-IEDAT-02-2015 Study

Wearable Assessments in the Clinic and Home in PD

Safety and Anti-Tumor Activity of TYRA-200 in Advanced Cholangiocarcinoma With Activating FGFR2 Gene Alterations

A Study Evaluating the Effect of Filgotinib Dose De-escalation in Participants With Ulcerative Colitis (UC) in Remission

Study of Safety, Tolerability and Efficacy of DFV890 in Participants With Familial Cold Auto-inflammatory Syndrome (FCAS)